Concepedia

Publication | Closed Access

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

DOI

227

Citations

0

References

2008

Year

David C. Klonoff, John B. Buse, Loretta L. Nielsen, Xuesong Guan, Christopher L. Bowlus, John H. Holcombe, Matthew Wintle, David Maggs
Current Medical Research and Opinion

No additional data available for this publication yet. Check back later!